Literature DB >> 14505654

Synthesis and testing of novel phenyl substituted side-chain analogues of classical cannabinoids.

Mathangi Krishnamurthy1, Antonio M Ferreira, Bob M Moore.   

Abstract

A series of novel phenyl substituted side-chain analogues of classical cannabinoids were synthesized and their CB1 and CB2 binding affinities were evaluated relative to Delta(8)-THC and compound 2. CB1 and CB2 binding assays indicate that the dimethyl and ketone analogues (3) and (6) display selectivity for the CB2 receptor in comparison to delta(8)-THC and compound 2. This study provides newer insights into the geometrical and functional group requirements of the ligand binding pockets of the CB1 and the CB2 receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505654     DOI: 10.1016/s0960-894x(03)00729-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma.

Authors:  Christopher Duntsch; Murali Krishna Divi; Terreia Jones; Qihong Zhou; Mathangi Krishnamurthy; Peter Boehm; George Wood; Allen Sills; Bob M Moore
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

2.  Cannabinoids as anticancer therapeutic agents.

Authors:  Olga Kovalchuk; Igor Kovalchuk
Journal:  Cell Cycle       Date:  2020-04-05       Impact factor: 4.534

3.  Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands.

Authors:  Dai Lu; Jianxin Guo; Richard I Duclos; Anna L Bowman; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2008-10-01       Impact factor: 7.446

4.  C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.

Authors:  Darryl D Dixon; Marcus A Tius; Ganesh A Thakur; Han Zhou; Anna L Bowman; Vidyanand G Shukla; Yan Peng; Alexandros Makriyannis
Journal:  Bioorg Med Chem Lett       Date:  2012-06-15       Impact factor: 2.823

5.  Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high.

Authors:  A Chicca; M A Schafroth; I Reynoso-Moreno; R Erni; V Petrucci; E M Carreira; J Gertsch
Journal:  Sci Adv       Date:  2018-10-24       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.